Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Brancaccio

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 12, 2012
[World Kidney Day 2012 in Italy. A success of the Italian Kidney Foundation]Diego Brancaccio, Vittorio Andreucci
Expert Opinion on Emerging Drugs|September 19, 2007
Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney diseaseMario Cozzolino, Diego Brancaccio
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2007
Is PTH a risk factor for cardiovascular calcifications in haemodialysis?Mario Cozzolino, Diego Brancaccio
Expert Opinion on Pharmacotherapy|April 2, 2008
Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidismMario Cozzolino, Diego Brancaccio
The International Journal of Artificial Organs|April 22, 2017
The Blue Journal after 40 yearsGeorge Dunea, Diego Brancaccio
Contributions to Nephrology|May 7, 2005
The mechanism of calcium deposition in soft tissuesDiego Brancaccio, Mario Cozzolino
Journal of Nephrology|May 31, 2011
CKD-MBD: an endless storyDiego Brancaccio, Mario Cozzolino
Journal of Nephrology|March 9, 2006
The continuous challenge of cardiovascular and bone and bone disease in uremic patients: clinical consequences of hyperphosphatemia and advanced therapeutic approachesDiego Brancaccio, Carmine Zoccali
Recent Patents on Cardiovascular Drug Discovery|January 29, 2008
Clinical consequences and novel therapy of hyperphosphatemia: Lanthanum carbonate for dialysis patientsMario Cozzolino, Diego Brancaccio
Kidney International|September 17, 2008
VDRAs versus calcimimetics: better safe than sorry?Mario Cozzolino, Diego Brancaccio
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 12, 2012
[World Kidney Day 2012 in Italy. A success of the Italian Kidney Foundation]Diego Brancaccio, Vittorio Andreucci
Expert Opinion on Emerging Drugs|September 19, 2007
Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney diseaseMario Cozzolino, Diego Brancaccio
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 30, 2007
Is PTH a risk factor for cardiovascular calcifications in haemodialysis?Mario Cozzolino, Diego Brancaccio
Expert Opinion on Pharmacotherapy|April 2, 2008
Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidismMario Cozzolino, Diego Brancaccio
The International Journal of Artificial Organs|April 22, 2017
The Blue Journal after 40 yearsGeorge Dunea, Diego Brancaccio
Contributions to Nephrology|May 7, 2005
The mechanism of calcium deposition in soft tissuesDiego Brancaccio, Mario Cozzolino
Journal of Nephrology|May 31, 2011
CKD-MBD: an endless storyDiego Brancaccio, Mario Cozzolino
Journal of Nephrology|March 9, 2006
The continuous challenge of cardiovascular and bone and bone disease in uremic patients: clinical consequences of hyperphosphatemia and advanced therapeutic approachesDiego Brancaccio, Carmine Zoccali
Recent Patents on Cardiovascular Drug Discovery|January 29, 2008
Clinical consequences and novel therapy of hyperphosphatemia: Lanthanum carbonate for dialysis patientsMario Cozzolino, Diego Brancaccio
Kidney International|September 17, 2008
VDRAs versus calcimimetics: better safe than sorry?Mario Cozzolino, Diego Brancaccio
Pageof 17